News & Analysis on Clinical Trial Services & Contract Research And Development
dispatches from CPhI
Regulatory pressure for risk-based supply chain management is increasing excipient suppliers’ audit burden according to the team preparing to launch the 'excipact' certification scheme as an independent association.
Despite a strong Q3, Icon has outlined plans for further cuts at its UK clinical pharmacology unit (CPU) as it rejigs its ‘weak’ early phase services business.
CDMO Aenova has continued its strategy of consolidation with the acquisition of Haupt Pharma.
UPDATE - Dispatches from CPhI
Dow says the acquisition of partner Bend Research is “good news” and will strengthen its developments in solving solubility and bioavailability issues in drug formulation.
Drug giant GlaxoSmithKline says operations have restarted at an OTC plant forced to close last week following a methane leak.
McKesson Group has completed the acquisition of logistics firm Celesio as it eyes a global strategy, targeting the European and Latin America markets.